{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:15:53Z","timestamp":1780413353762,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00059-026-05373-x","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:29:08Z","timestamp":1772184548000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["T-TEER\u2014interventional repair of tricuspid regurgitation","T-TEER\u00a0\u2013 interventionelle Rekonstruktion bei Trikuspidalklappeninsuffizienz"],"prefix":"10.1007","volume":"51","author":[{"given":"Dominik","family":"Berliner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Schallhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"20","key":"5373_CR1","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1056\/NEJMra2216709","volume":"388","author":"RT Hahn","year":"2023","unstructured":"Hahn\u00a0RT (2023) Tricuspid Regurgitation. New England Journal of Medicine 388(20):1876\u20131891. https:\/\/doi.org\/10.1056\/NEJMra2216709","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"5373_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcmg.2018.06.014","volume":"12","author":"Y Topilsky","year":"2019","unstructured":"Topilsky\u00a0Y et\u00a0al (2019) Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. JACC: Cardiovascular Imaging 12(3):433\u2013442. https:\/\/doi.org\/10.1016\/j.jcmg.2018.06.014","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"44","key":"5373_CR3","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","volume":"46","author":"F Praz","year":"2025","unstructured":"Praz\u00a0F et\u00a0al (2025) 2025 ESC\/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J Qual Care Clin Outcomes 46(44):4635\u20134736. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf194","journal-title":"European Heart Journal"},{"issue":"2","key":"5373_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ehjci\/jez216","volume":"21","author":"E Chorin","year":"2019","unstructured":"Chorin\u00a0E et\u00a0al (2019) Tricuspid regurgitation and long-term clinical outcomes. European Heart Journal - Cardiovascular Imaging 21(2):157\u201365. https:\/\/doi.org\/10.1093\/ehjci\/jez216","journal-title":"European Heart Journal - Cardiovascular Imaging"},{"issue":"3","key":"5373_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.mayocp.2024.09.022","volume":"100","author":"HO Kucuk","year":"2025","unstructured":"Kucuk\u00a0HO et\u00a0al (2025) Natural History of Tricuspid Valve Regurgitation: Understanding the Limitations of Medical Therapy. Mayo Clin Proc Digit Health 100(3):440\u2013451. https:\/\/doi.org\/10.1016\/j.mayocp.2024.09.022","journal-title":"Mayo Clinic Proceedings"},{"issue":"6","key":"5373_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ejhf.2858","volume":"25","author":"G Heitzinger","year":"2023","unstructured":"Heitzinger\u00a0G et\u00a0al (2023) Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum. ESC Heart Fail 25(6):857\u2013867. https:\/\/doi.org\/10.1002\/ejhf.2858","journal-title":"European Journal of Heart Failure"},{"issue":"20","key":"5373_CR7","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","volume":"137","author":"MA Konstam","year":"2018","unstructured":"Konstam\u00a0MA et\u00a0al (2018) Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation 137(20):e578\u2013e622. https:\/\/doi.org\/10.1161\/CIR.0000000000000560","journal-title":"Circulation"},{"issue":"3","key":"5373_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/joim.13312","volume":"290","author":"SC Butcher","year":"2021","unstructured":"Butcher\u00a0SC et\u00a0al (2021) Renal function in patients with significant tricuspid regurgitation: pathophysiological mechanisms and prognostic implications. Journal of Internal Medicine 290(3):715\u2013727. https:\/\/doi.org\/10.1111\/joim.13312","journal-title":"Journal of Internal Medicine"},{"issue":"12","key":"5373_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9149(02)02886-2","volume":"90","author":"GT Lau","year":"2002","unstructured":"Lau\u00a0GT et al (2002) Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. The American Journal of Cardiology 90(12):1405\u20131409. https:\/\/doi.org\/10.1016\/S0002-9149(02)02886-2","journal-title":"The American Journal of Cardiology"},{"issue":"10","key":"5373_CR10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cardfail.2008.07.236","volume":"14","author":"MT Maeder","year":"2008","unstructured":"Maeder\u00a0MT et al (2008) Tricuspid Regurgitation Contributes to Renal Dysfunction in Patients With Heart Failure. J\u00a0Card Fail 14(10):824\u2013830. https:\/\/doi.org\/10.1016\/j.cardfail.2008.07.236","journal-title":"Journal of Cardiac Failure"},{"issue":"7","key":"5373_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jcin.2024.02.034","volume":"17","author":"GA Welle","year":"2024","unstructured":"Welle\u00a0GA et\u00a0al (2024) New Approaches to Assessment and Management of Tricuspid Regurgitation Before Intervention. JACC Cardiovasc Interv 17(7):837\u2013858. https:\/\/doi.org\/10.1016\/j.jcin.2024.02.034","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"17","key":"5373_CR12","first-page":"551","volume":"121","author":"TJ Stocker","year":"2024","unstructured":"Stocker\u00a0TJ et al (2024) The Diagnosis and Treatment of Tricuspid Regurgitation. Dtsch Arztebl International 121(17):551\u2013558","journal-title":"Dtsch Arztebl International"},{"key":"5373_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1022755","volume":"9","author":"M Gavazzoni","year":"2022","unstructured":"Gavazzoni\u00a0M et\u00a0al (2022) The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype. Front Cardiovasc Med 9:1022755. https:\/\/doi.org\/10.3389\/fcvm.2022.1022755","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"42","key":"5373_CR14","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1093\/eurheartj\/ehae544","volume":"45","author":"KM Talha","year":"2024","unstructured":"Talha\u00a0KM et al (2024) Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation. Eur Heart J Qual Care Clin Outcomes 45(42):4539\u20134541. https:\/\/doi.org\/10.1093\/eurheartj\/ehae544","journal-title":"European Heart Journal"},{"issue":"45","key":"5373_CR15","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1093\/eurheartj\/ehaa643","volume":"41","author":"J Dreyfus","year":"2020","unstructured":"Dreyfus\u00a0J et\u00a0al (2020) Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J Qual Care Clin Outcomes 41(45):4304\u20134317. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa643","journal-title":"European Heart Journal"},{"issue":"7","key":"5373_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/eurheartj\/ehab679","volume":"43","author":"J Dreyfus","year":"2021","unstructured":"Dreyfus\u00a0J et\u00a0al (2021) TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J Qual Care Clin Outcomes 43(7):654\u2013662. https:\/\/doi.org\/10.1093\/eurheartj\/ehab679","journal-title":"European Heart Journal"},{"issue":"6","key":"5373_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11886-024-02051-4","volume":"26","author":"MV Madhavan","year":"2024","unstructured":"Madhavan\u00a0MV et al (2024) Transcatheter Therapy for the Tricuspid Valve: A\u00a0Focused Review of Edge-to-Edge Repair and Orthotopic Valve Replacement. Curr Cardiol Rep 26(6):459\u2013474. https:\/\/doi.org\/10.1007\/s11886-024-02051-4","journal-title":"Current Cardiology Reports"},{"issue":"2","key":"5373_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ehjimp\/qyae017","volume":"2","author":"M Mazzola","year":"2024","unstructured":"Mazzola\u00a0M et\u00a0al (2024) Transthoracic and transoesophageal echocardiography for tricuspid transcatheter edge-to-edge repair: a step-by-step protocol. Eur Heart J Imaging Methods Pract 2(2):qyae017. https:\/\/doi.org\/10.1093\/ehjimp\/qyae017","journal-title":"European Heart Journal - Imaging Methods and Practice"},{"issue":"23","key":"5373_CR19","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.jcin.2025.09.033","volume":"18","author":"J v Stein","year":"2025","unstructured":"v Stein\u00a0J et\u00a0al (2025) Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiac Implantable Electronic Devices. JACC Cardiovasc Interv 18(23):2878\u20132891. https:\/\/doi.org\/10.1016\/j.jcin.2025.09.033","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"8","key":"5373_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/eurheartj\/ehad585","volume":"45","author":"J Dreyfus","year":"2023","unstructured":"Dreyfus\u00a0J et\u00a0al (2023) TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation. Eur Heart J Qual Care Clin Outcomes 45(8):586\u2013597. https:\/\/doi.org\/10.1093\/eurheartj\/ehad585","journal-title":"European Heart Journal"},{"issue":"11","key":"5373_CR21","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1002\/ejhf.3797","volume":"27","author":"G Heitzinger","year":"2025","unstructured":"Heitzinger G et\u00a0al (2025) Left ventricular ejection fraction and benefit of tricuspid valve interventions \u2013 insights from the international TRIGISTRY. ESC Heart Fail 27(11):2634\u20132643. https:\/\/doi.org\/10.1002\/ejhf.3797","journal-title":"European Journal of Heart Failure"},{"issue":"7","key":"5373_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jcmg.2024.04.008","volume":"17","author":"M Ger\u00e7ek","year":"2024","unstructured":"Ger\u00e7ek\u00a0M et\u00a0al (2024) GLIDE Score: Scoring System for Prediction of Procedural Success in Tricuspid Valve Transcatheter Edge-to-Edge Repair. JACC: Cardiovascular Imaging 17(7):729\u2013742. https:\/\/doi.org\/10.1016\/j.jcmg.2024.04.008","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"10213","key":"5373_CR23","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/S0140-6736(19)32600-5","volume":"394","author":"G Nickenig","year":"2019","unstructured":"Nickenig\u00a0G et\u00a0al (2019) Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6\u2011month outcomes of the TRILUMINATE single-arm study. The Lancet 394(10213):2002\u20132011. https:\/\/doi.org\/10.1016\/S0140-6736(19)32600-5","journal-title":"The Lancet"},{"issue":"3","key":"5373_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jacc.2020.11.038","volume":"77","author":"P Lurz","year":"2021","unstructured":"Lurz\u00a0P et\u00a0al (2021) Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation. JACC Adv 77(3):229\u2013239. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.038","journal-title":"JACC"},{"issue":"18","key":"5373_CR25","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.jcin.2024.05.036","volume":"17","author":"G Nickenig","year":"2024","unstructured":"Nickenig\u00a0G et\u00a0al (2024) Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: 3\u2011Year Outcomes From the TRILUMINATE Study. JACC Cardiovasc Interv 17(18):2113\u20132122. https:\/\/doi.org\/10.1016\/j.jcin.2024.05.036","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"20","key":"5373_CR26","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2300525","volume":"388","author":"P Sorajja","year":"2023","unstructured":"Sorajja P et\u00a0al (2023) Transcatheter Repair for Patients with Tricuspid Regurgitation. New England Journal of Medicine 388(20):1833\u20131842. https:\/\/doi.org\/10.1056\/NEJMoa2300525","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"5373_CR27","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/ejhf.3274","volume":"26","author":"L Stolz","year":"2024","unstructured":"Stolz\u00a0L et\u00a0al (2024) Residual tricuspid regurgitation after tricuspid transcatheter edge-to-edge repair: Insights into the EuroTR registry. ESC Heart Fail 26(8):1850\u20131860. https:\/\/doi.org\/10.1002\/ejhf.3274","journal-title":"European Journal of Heart Failure"},{"issue":"7","key":"5373_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2024.05.006","volume":"84","author":"P Lurz","year":"2024","unstructured":"Lurz\u00a0P et\u00a0al (2024) Real-World 1\u2011Year Results of Tricuspid Edge-to-Edge Repair From the bRIGHT Study. JACC Adv 84(7):607\u2013616. https:\/\/doi.org\/10.1016\/j.jacc.2024.05.006","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"5373_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2023.05.008","volume":"82","author":"P Lurz","year":"2023","unstructured":"Lurz\u00a0P et\u00a0al (2023) Short-Term Outcomes of Tricuspid Edge-to-Edge Repair in Clinical Practice. JACC Adv 82(4):281\u2013291. https:\/\/doi.org\/10.1016\/j.jacc.2023.05.008","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"5373_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jacc.2024.10.068","volume":"85","author":"MG Wild","year":"2025","unstructured":"Wild\u00a0MG et\u00a0al (2025) Transcatheter Valve Repair for Tricuspid Regurgitation: 1\u2011Year Results From a Large European Real-World Registry. JACC Adv 85(3):220\u2013231. https:\/\/doi.org\/10.1016\/j.jacc.2024.10.068","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"5373_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.124.014825","volume":"18","author":"TM Shimoda","year":"2025","unstructured":"Shimoda\u00a0TM et\u00a0al (2025) Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results. Circulation: Cardiovascular Interventions 18(1):e014825. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.124.014825","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"2","key":"5373_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/jama.2024.21189","volume":"333","author":"E Donal","year":"2025","unstructured":"Donal E et\u00a0al (2025) Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The Tri.Fr Randomized Clinical Trial. JAMA 333(2):124\u2013132. https:\/\/doi.org\/10.1001\/jama.2024.21189","journal-title":"JAMA"},{"issue":"23","key":"5373_CR33","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.125.074536","volume":"151","author":"S Kar","year":"2025","unstructured":"Kar\u00a0S et\u00a0al (2025) Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial. Circulation 151(23):1630\u20131638. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.074536","journal-title":"Circulation"},{"issue":"8","key":"5373_CR34","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/ejhf.3757","volume":"27","author":"D Tomasoni","year":"2025","unstructured":"Tomasoni\u00a0D et\u00a0al (2025) Heart failure hospitalizations and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair: Insights from EuroTR. ESC Heart Fail 27(8):1559\u201369. https:\/\/doi.org\/10.1002\/ejhf.3757","journal-title":"European Journal of Heart Failure"},{"issue":"3","key":"5373_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jacc.2024.09.009","volume":"85","author":"JL Cavalcante","year":"2025","unstructured":"Cavalcante\u00a0JL et\u00a0al (2025) Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling. JACC Adv 85(3):250\u2013261. https:\/\/doi.org\/10.1016\/j.jacc.2024.09.009","journal-title":"JACC"},{"issue":"25","key":"5373_CR36","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.jacc.2024.08.044","volume":"84","author":"UP Jorde","year":"2024","unstructured":"Jorde\u00a0UP et\u00a0al (2024) Impact of Renal and Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair. JACC Adv 84(25):2446\u20132456. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.044","journal-title":"JACC"},{"key":"5373_CR37","doi-asserted-by":"publisher","unstructured":"Felbel D et al (2024) Effective tricuspid regurgitation reduction is associated with renal improvement and reduced heart failure hospitalization. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2024.1452446.","DOI":"10.3389\/fcvm.2024.1452446"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-026-05373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-026-05373-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-026-05373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:45:12Z","timestamp":1780411512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-026-05373-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5373"],"URL":"https:\/\/doi.org\/10.1007\/s00059-026-05373-x","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.\u00a0Berliner received honoraria for lectures\/consulting from Abbott Cardiovascular, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Edwards Lifesciences, Novartis, and Pfizer. J.\u00a0Bauersachs received honoraria for lectures\/consulting from Abbott, Novartis, Bayer, Pfizer, Boehringer Ingelheim, AstraZeneca, Lilly, Cardior, CVRx, BMS, Amgen, Edwards, NovoNordisk, Roche, Zoll; and research support for the department from Zoll, CVRx, Abiomed, Norgine, Roche. S.\u00a0Schallhorn declares that he has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}